share_log

Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Lloyd Emerson

Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Lloyd Emerson

美国血液技术 | 4:持股变动声明-董事 Johnson Lloyd Emerson
美股SEC公告 ·  07/27 04:29
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息